Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?

被引:6
|
作者
Versmissen, Jorie [1 ,2 ]
Verdonk, Koen [1 ]
Lafeber, Melvin [1 ]
van den Akker, Johannes P. C. [3 ]
Hunfeld, Nicole G. M. [2 ,3 ]
Hoorn, Ewout J. [1 ]
Danser, A. H. Jan [1 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Internal Med, Rotterdam, Netherlands
[2] Erasmus MC Univ Med Ctr, Dept Hosp Pharm, Rotterdam, Netherlands
[3] Erasmus MC Univ Med Ctr, Dept Intens Care, Rotterdam, Netherlands
关键词
RECEPTOR BLOCKERS; ACE2; INFLAMMATION; HYPERTENSION; INHIBITION; SYSTEM; HEART;
D O I
10.1097/HJH.0000000000002472
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:1196 / 1197
页数:2
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
    Alabsi, Sarah
    Dhole, Atharva
    Hozayen, Sameh
    Chapman, Scott A.
    [J]. MICROORGANISMS, 2023, 11 (03)
  • [2] Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection
    Paul, Deepraj
    Mohankumar, Suresh K.
    Thomas, Rhian S.
    Kheng, Chai B.
    Basavan, Duraiswamy
    [J]. CURRENT DRUG TARGETS, 2022, 23 (04) : 364 - 372
  • [3] Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection
    Vargas-Rodriguez, Jose R.
    Garza-Veloz, Idalia
    Flores-Morales, Virginia
    Badillo-Almaraz, Jose I.
    Rocha-Pizana, Maria R.
    Valdes-Aguayo, Jose J.
    Martinez-Fierro, Margarita L.
    [J]. FRONTIERS IN MEDICINE, 2022, 8
  • [4] Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
    Murray, Eleanor
    Tomaszewski, Maciej
    Guzik, Tomasz J.
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (07) : E87 - E89
  • [5] Angiotensin-Converting Enzyme Type 2 as a Molecular Mediator for Infection of Cells with SARS-CoV and SARS-CoV-2 Viruses
    Shpakov A.O.
    [J]. Neuroscience and Behavioral Physiology, 2021, 51 (3) : 381 - 389
  • [6] Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
    Han, Kun
    Blair, Robert, V
    Iwanaga, Naoki
    Liu, Fengming
    Russell-Lodrigue, Kasi E.
    Qin, Zhongnan
    Midkiff, Cecily C.
    Golden, Nadia A.
    Doyle-Meyers, Lara A.
    Kabir, Mohammad E.
    Chandler, Kristin E.
    Cutrera, Kellie L.
    Ren, Mi
    Monjure, Christopher J.
    Lehmicke, Gabrielle
    Fischer, Tracy
    Beddingfield, Brandon
    Wanek, Alanna G.
    Birnbaum, Angela
    Maness, Nicholas J.
    Roy, Chad J.
    Datta, Prasun K.
    Rappaport, Jay
    Kolls, Jay K.
    Qin, Xuebin
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 64 (01) : 79 - 88
  • [7] Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy
    Lennol, Matthew P.
    Garcia-Ayllon, Maria-Salud
    Esteban, Mariano
    Garcia-Arriaza, Juan
    Saez-Valero, Javier
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
    Barker, Harlan
    Parkkila, Seppo
    [J]. PLOS ONE, 2020, 15 (10):
  • [9] SCREENING OF ANGIOTENSIN-CONVERTING ENZYME-2 AND FURIN INHIBITORS AS DRUG LEADS AGAINST SARS-COV2
    Bency, Jesvin
    [J]. APPLIED BIOLOGICAL RESEARCH, 2023, 25 (03) : 253 - 260
  • [10] Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2
    Hallaj, Shahin
    Ghorbani, Anahita
    Mousavi-Aghdas, Seyed Ali
    Mirza-Aghazadeh-Attari, Mohammad
    Sevbitov, Andrey
    Hashemi, Vida
    Hallaj, Tooba
    Jadidi-Niaragh, Farhad
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (02): : 192 - 205